Conditional internalization of PEGylated nanomedicines by PEG engagers for triple negative breast cancer therapy

 

Yu-Cheng Su, Pierre-Alain Burnouf, Kuo-Hsiang Chuang, Bing-Mae Chen, Tian-Lu Cheng & Steve R. Roffler

Nature Communications
2017 vol: 8 Article number: 15507 doi: 10.1038/ncomms15507

Abstract

Triple-negative breast cancer (TNBC) lacks effective treatment options due to the absence of traditional therapeutic targets. The epidermal growth factor receptor (EGFR) has emerged as a promising target for TNBC therapy because it is overexpressed in about 50% of TNBC patients. Here we describe a PEG engager that simultaneously binds polyethylene glycol and EGFR to deliver PEGylated nanomedicines to EGFR+ TNBC. The PEG engager displays conditional internalization by remaining on the surface of TNBC cells until contact with PEGylated nanocarriers triggers rapid engulfment of nanocargos. PEG engager enhances the anti-proliferative activity of PEG-liposomal doxorubicin to EGFR+ TNBC cells by up to 100-fold with potency dependent on EGFR expression levels. The PEG engager significantly increases retention of fluorescent PEG probes and enhances the antitumour activity of PEGylated liposomal doxorubicin in human TNBC xenografts. PEG engagers with specificity for EGFR are promising for improved treatment of EGFR+ TNBC patients.

View Publication

Topics: Antibodies, Detergents, Macromolecular, Polymers, Monolith – MicroScale Thermophoresis, MST, Proteins, Publications

 

 

Previous Article
Structural basis of egg coat-sperm recognition at fertilization
Structural basis of egg coat-sperm recognition at fertilization

Up next
The monoclonal S9.6 antibody exhibits highly variable binding affinities towards different R-loop sequences
The monoclonal S9.6 antibody exhibits highly variable binding affinities towards different R-loop sequences

×

Sign up to receive
the latest NanoTemper news, product updates, event announcements and more

First Name
Last Name
Company Name
Country
State
Province
State
Region
State
Canton
Agree to Subscribe & Privacy Policy*
*I have fully read, understood and agree to the Privacy Policy. I accept the storing and processing of my personal data by NanoTemper as described in the Privacy Policy.

By completing this form, you provide us consent to contact you with educational content, news and information about our products, services and events. You may unsubscribe at any time.
Thank you!
Error - something went wrong!